Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): A harmonised study protocol for two phase i clinical trials comparing intradermal and intranodal cell administration

  1. Willekens, B.
  2. Presas-Rodríguez, S.
  3. Mansilla, M.J.
  4. Derdelinckx, J.
  5. Lee, W.-P.
  6. Nijs, G.
  7. De Laere, M.
  8. Wens, I.
  9. Cras, P.
  10. Parizel, P.
  11. Van Hecke, W.
  12. Ribbens, A.
  13. Billiet, T.
  14. Adams, G.
  15. Couttenye, M.-M.
  16. Navarro-Barriuso, J.
  17. Teniente-Serra, A.
  18. Quirant-Sánchez, B.
  19. Lopez-Diaz De Cerio, A.
  20. Inogés, S.
  21. Prosper, F.
  22. Kip, A.
  23. Verheij, H.
  24. Gross, C.C.
  25. Wiendl, H.
  26. Van Ham, M.
  27. Ten Brinke, A.
  28. Barriocanal, A.M.
  29. Massuet-Vilamajó, A.
  30. Hens, N.
  31. Berneman, Z.
  32. Martínez-Cáceres, E.
  33. Cools, N.
  34. Ramo-Tello, C.
  35. Show all authors +
Journal:
BMJ Open

ISSN: 2044-6055

Year of publication: 2019

Volume: 9

Issue: 9

Type: Article

DOI: 10.1136/BMJOPEN-2019-030309 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus